Filing Details

Accession Number:
0001181431-14-008459
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-02-21 17:09:41
Reporting Period:
2014-02-20
Filing Date:
2014-02-21
Accepted Time:
2014-02-21 17:09:41
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
879169 Incyte Corp INCY Services-Commercial Physical & Biological Research (8731) 943136539
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1236927 A Paul Friedman Experimental Station
Route 141 &Amp; Henry Clay Road
Wilmington DE 19880
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-02-20 33,354 $3.11 450,872 No 4 M Direct
Common Stock Disposition 2014-02-20 33,354 $63.51 417,518 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2014-02-20 33,354 $0.00 33,354 $3.11
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2016-01-26 No 4 M Direct
Footnotes
  1. Beginning January 27, 2009, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years.
  2. Represents weighted average sale price. Actual sales prices ranged from $63.50-$63.55.
  3. Reporting person undertakes to provide upon request by Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares.